[1]
“EFFECTIVENESS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC HEART FAILURE”, RS Global - World Science, no. 1(79), Mar. 2023, doi: 10.31435/rsglobal_ws/30032023/7957.